captopril (Capoten) reduces the risk of MI, stroke, and death in patients with hypertension
August 1998
New evidence now suggests that captopril (Capoten) reduces the risk of MI, stroke, and death inpatients with hypertension.
This is important.
Up until now, only beta-blockers and diuretics have been shown to reduce cardiovascular morbidityand mortality.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote